Battling the two-headed dragon of prostate cancer targeted therapy
Neoadjuvant intense androgen deprivation therapy for high-risk localized prostate cancer is an emerging but unproven treatment paradigm that is hoped to delay or prevent disease recurrence. We found that a patient enrolled in a clinical trial harbored two completely independent prostate cancers that...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis Group
2020-07-01
|
| Cyfres: | Molecular & Cellular Oncology |
| Pynciau: | |
| Mynediad Ar-lein: | http://dx.doi.org/10.1080/23723556.2020.1745037 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|